Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06456671 · ClinicalTrials.gov registry record · NA
Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 440
- Enrollment target
NCT06456671: Completed NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT06456671 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 440 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06456671, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 440 participants
- Enrollment target
Study Summary
This study will investigate the relative appeal (abuse liability) of novel tobacco products, how the appeal is modulated by relative price, user type, and how novel products may substitute for one another.
Primary Outcome
Participants completed purchasing trials in an Experimental Tobacco Marketplace (ETM) with cigarettes increasing in price. Other product prices in the ETM depend on the experimental condition. The degree to which other nicotine/tobacco products substitute for conventional cigarettes as a function of novel product (nicotine vaping products, heated tobacco products, nicotine pouch products) prices was assessed. Participants completed the ETM task under four within-subject conditions: Control: Al
Interventions
- OTHER All nicotine/ tobacco products at market price
- OTHER Nicotine vaping products at 1/2 market price
- OTHER Heated tobacco products at 1/2 market price.
- OTHER Nicotine pouch products at 1/2 market price.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2024-07-29 |
| Est. Completion | 2025-01-07 |
| Phase | NA |
What the finished NCT06456671 record still lists
NCT06456671 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 4 interventions - of which All nicotine/ tobacco products at market price is the first listed.
NCT06456671 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06456671 about?
NCT06456671 is a clinical study titled "Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study". This study will investigate the relative appeal (abuse liability) of novel tobacco products, how the appeal is modulated by relative price, user type, and how novel products may substitute for one another.
What is the current status of trial NCT06456671?
This trial is currently completed. It is a NA study. The enrollment target is 440 participants. The study started on 2024-07-29. Estimated completion is 2025-01-07.
What interventions are being tested in trial NCT06456671?
The interventions under investigation include: All nicotine/ tobacco products at market price (OTHER), Nicotine vaping products at 1/2 market price (OTHER), Heated tobacco products at 1/2 market price. (OTHER), Nicotine pouch products at 1/2 market price. (OTHER).
Who is sponsoring clinical trial NCT06456671?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06456671's enrollment target sits among peer trials
440 233rd of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI